ArticleResearch square2023

Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19.

Panos Arvanitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.